Want to see KR:183490 full AI Analyst Report?
Enzychem Lifesciences Corp. (183490) Financial Statements
Enzychem Lifesciences Corp. Financial Overview
Enzychem Lifesciences Corp.'s market cap is currently $76.86B. The company's EPS TTM is $-233.30; its P/E ratio is -8.16; Enzychem Lifesciences Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 67.75B | $ 77.38B | $ 76.04B | $ 26.64B | $ 22.98B |
| Gross Profit | $ 3.38B | $ 4.31B | $ 4.35B | $ 2.42B | $ 286.72M |
| Operating Income | $ -13.09B | $ -13.19B | $ -14.36B | $ -14.66B | $ -20.75B |
| EBITDA | $ -14.90B | $ -18.39B | $ -5.75B | $ -13.16B | $ -17.89B |
| Net Income | $ -18.13B | $ -22.11B | $ -9.33B | $ -25.09B | $ -27.86B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 92.82B | $ 117.07B | $ 137.35B | $ 192.86B | $ 94.59B |
| Total Assets | $ 148.59B | $ 181.74B | $ 211.55B | $ 247.55B | $ 133.08B |
| Total Debt | $ 4.84B | $ 4.88B | $ 5.66B | $ 37.78B | $ 51.98B |
| Net Debt | $ -3.00B | $ -5.42B | $ -9.81B | $ 30.10B | $ 49.19B |
| Total Liabilities | $ 9.83B | $ 20.26B | $ 16.92B | $ 45.81B | $ 58.42B |
| Stockholders' Equity | $ 137.54B | $ 160.35B | $ 193.52B | $ 201.74B | $ 74.66B |
| Cash Flow | |||||
| Free Cash Flow | $ -11.79B | $ -1.06B | $ -12.56B | $ -22.33B | $ -24.47B |
| Operating Cash Flow | $ -11.01B | $ -573.93M | $ -10.26B | $ -14.32B | $ -18.59B |
| Investing Cash Flow | $ 11.93B | $ 7.36B | $ 53.56B | $ -109.23B | $ -9.73B |
| Financing Cash Flow | $ -3.34B | $ -12.14B | $ -35.50B | $ 128.50B | $ 29.26B |
Currency in KRW